Short Interest in Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Rises By 51.1%

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) was the recipient of a large increase in short interest in the month of August. As of August 14th, there was short interest totaling 82,653 shares, an increase of 51.1% from the July 30th total of 54,710 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 2,525,183 shares, the days-to-cover ratio is presently 0.0 days.

Advanced Medical Isotope Stock Performance

RDGL opened at $0.05 on Thursday. The stock has a market capitalization of $26.72 million, a PE ratio of -5.41 and a beta of -0.72. Advanced Medical Isotope has a one year low of $0.05 and a one year high of $0.12. The business’s 50 day moving average price is $0.06 and its 200 day moving average price is $0.07.

Advanced Medical Isotope Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.